BFRG: Rasio silihan jangka dawa marang modal Bullfrog AI Holdings, Inc.

Lambang korporat lan logo Bullfrog AI (BFRG)

The Bullfrog AI bioinformatics team aims to transform pharmacology through AI developments. The history of long-term debt-to-equity demonstrates financial stability, where the 0.00 mark records this metric. High potential is driven by the bfLEAP drug discovery platform, while a strong market barrier is created by the complexity for partners to switch analytical software, ensuring margin stability.

bullfrogai.com (BFRG) - Utang jangka dawa marang ekuitas saka 28.04.2023 nganti 30.10.2026
Produk asli bullfrogai.com

The development of the bfLEAP platform for pharmaceuticals requires significant capital expenditures in AI infrastructure for Bullfrog AI Holdings (BFRG). Financing these costs through borrowed funds directly impacts the calculation of the long-term debt-to-equity ratio. This metric measures the proportion of loans with maturities exceeding one year relative to the company's equity. It reveals financial stability and the extent of the business's reliance on external leverage. Analyzing the long-term debt-to-equity ratio allows for an assessment of the balance between debt load and shareholder value.

Perusahaan pesaing

Veeva Systems (VEEV) - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas DOCS (Doximity Corp)|Rasio silihan jangka dawa marang modal HQY|Waystar Holding Corp. - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal CRVL|PRVA - Utang jangka dawa marang ekuitas|Huron Consulting Group Inc. (HURN) - Rasio utang jangka dawa marang ekuitas|CERT: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Omnicell Health (OMCL)|GDRX (GoodRx Holdings, Inc.) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal SDGR (schrodinger.com)|Utang jangka dawa marang modal PHR|Utang jangka dawa marang ekuitas OMDA (Omada Health, Inc.)|Evolent - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal HealthStream Learning HSTM|DH - Utang jangka dawa marang ekuitas|CCSI: Utang jangka dawa marang ekuitas|agilon health (AGL) - Utang jangka dawa marang ekuitas|ABSI (Absci Corp) - Utang jangka dawa marang ekuitas|SY (SoYoung) - Utang jangka dawa marang modal|nrchealth.com - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas Spok Holdings, Inc. (SPOK)|OPRX (optimizerx.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas TruBridge TBRG|Simulations Plus Inc (SLP) - Kewajiban jangka dawa marang modal|SOPHiA GENETICS S.A. - Utang jangka dawa marang modal|Tanggungan utang jangka dawa marang ekuitas Health Catalyst Inc (HCAT)|CCLD (carecloud.com) - Rasio utang jangka dawa marang ekuitas|researchsolutions.com - Koefisien utang jangka dawa marang modal|DLHC (DLH Corp) - Utang jangka dawa marang modal|Utang jangka dawa marang modal OneMedNet Corp.|Utang jangka dawa marang modal SCNX|Rasio tanggungan utang jangka dawa marang modal Healthcare Triangle Corporation|iSpecimen - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal WORX|MSP Recovery - Utang jangka dawa marang modal|Koefisien utang jangka dawa marang modal ICCT (iCoreConnect Inc.)|TRxADE (MEDS) - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal Orgenesis Corporation (ORGS)|Utang jangka dawa marang ekuitas R1 RCM, Inc.|Utang jangka dawa marang ekuitas SHCR|Utang jangka dawa marang modal STRM|Syra Health Corp - Rasio utang jangka dawa marang modal|Utang jangka dawa marang modal AMEH (Apollo Medical Holdings, Inc.)|Rasio tanggungan utang jangka dawa marang modal Model N Corporation (MODN)|NXGN - Utang jangka dawa marang ekuitas